Beilu Pharma is a leader and pioneer in the Contrast Media field in China. It provides a wide range of Contrast Media products for diagnostic imaging and interventional therapy, and it also offers Anti-diabetic and Anti-anxiety medicines to improve the treatment and help healthcare professionals solve problems.

The success of developing and marketing Contrast Media in the local market promotes us to explore overseas market and Beilu Pharma has currently expanded its footprints across Southeast Asia, Africa, Latin America, and Middle East markets. In 2020, Beilu Pharma successfully completed the acquisition of one of the largest Contrast Media API manufacturers-Zhejiang Hichi Pharmaceutical Co., Ltd. and upgraded the strategic layout of industrial chain integration.

Beilu Pharma is open to collaborating with any interested and relevant parties worldwide and we will continue to strive to provide high-quality products at a competitive price.